Clinical Experiences of Using Circulating Tumor DNA

In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).

Related Videos
Related Content

New Long-Term KEYNOTE-716 Data Presented at ASCO 2023

June 5th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

SLIDESHOW: Highlights from the 2023 American College of Mohs Surgery Meeting

May 11th 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

ACMS Case Study Explores Tumor Removal in Posterior Lamella

May 8th 2023

Insight from Anant Madabhushi, PhD on AI in Dermatologic Care

May 7th 2023

New Long-Term KEYNOTE-716 Data Presented at ASCO 2023

June 5th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

SLIDESHOW: Highlights from the 2023 American College of Mohs Surgery Meeting

May 11th 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

ACMS Case Study Explores Tumor Removal in Posterior Lamella

May 8th 2023

Insight from Anant Madabhushi, PhD on AI in Dermatologic Care

May 7th 2023

New Long-Term KEYNOTE-716 Data Presented at ASCO 2023

June 5th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

SLIDESHOW: Highlights from the 2023 American College of Mohs Surgery Meeting

May 11th 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

ACMS Case Study Explores Tumor Removal in Posterior Lamella

May 8th 2023

Insight from Anant Madabhushi, PhD on AI in Dermatologic Care

May 7th 2023
© 2023 MJH Life Sciences

All rights reserved.